11.23USD-1.14%Mkt Cap: 385.80M USDP/E: —Last update: 2026-05-22
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene …
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap385.80M USD
Enterprise Value206.38M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-37.92M USD
Revenue/Share—
Last Price11.23 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees19
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS08205P1003
Valuation
P/E (Trailing)—
P/E (Forward)-1.21
PEG—
EV/EBITDA-4.43
EV/Revenue—
P/S—
P/B2.13
EPS (TTM)-0.93
EPS (Forward)-9.42
52W Range
9.85019% of range17.15
52W High17.15 USD
52W Low9.850 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-38.97%
ROA-38.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.59M USD
CapEx (TTM)18.00K USD
FCF Margin—
FCF Yield-1.85%
Net Debt-183.88M USD
Net Debt/EBITDA3.95
Balance Sheet
Debt/Equity0.01
Current Ratio56.82
Quick Ratio56.43
Book Value/Sh5.337 USD
Cash/Share5.378 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 18, 2019
Splits
Last Split1:17
Split DateJul 26, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)24.33 USD
Target Range17.00 USD – 32.00 USD
# Analysts6
Ownership
Shares Out.34.35M
Float17.87M
Insiders2.70%
Institutions98.25%
Short Interest
Short Ratio21.4d
Short % Float11.94%
Short % Out.6.75%
Shares Short2.32M
Short (prev mo.)2.31M
Technical
SMA 5011.81 (-4.9%)
SMA 20012.71 (-11.6%)
Beta0.28
S&P 52W Chg28.31%
Avg Vol (30d)102.73K
Avg Vol (10d)85.48K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—